Skip to main content

Peer Review reports

From: Targeted immune epitope prediction to HHLA2 and MAGEB5 protein variants as therapeutic approach to related viral diseases

Original Submission
2 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
16 Feb 2021 Reviewed Reviewer Report - Balaji Banoth
20 Feb 2021 Reviewed Reviewer Report
22 Feb 2021 Reviewed Reviewer Report
27 Apr 2021 Author responded Author comments - Daniel Achinko
Resubmission - Version 4
27 Apr 2021 Submitted Manuscript version 4
28 Apr 2021 Author responded Author comments - Daniel Achinko
Resubmission - Version 5
28 Apr 2021 Submitted Manuscript version 5
4 May 2021 Reviewed Reviewer Report - Balaji Banoth
7 May 2021 Reviewed Reviewer Report
9 Jun 2021 Reviewed Reviewer Report
18 Jun 2021 Author responded Author comments - Daniel Achinko
Resubmission - Version 6
18 Jun 2021 Submitted Manuscript version 6
Publishing
20 Jul 2021 Editorially accepted
28 Jul 2021 Article published 10.1186/s12865-021-00440-w

You can find further information about peer review here.

Back to article page